Form 8-K - Current report:
SEC Accession No. 0001193125-24-259815
Filing Date
2024-11-15
Accepted
2024-11-15 16:05:56
Documents
14
Period of Report
2024-11-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d844835d8k.htm   iXBRL 8-K 33171
2 EX-10.1 d844835dex101.htm EX-10.1 337004
  Complete submission text file 0001193125-24-259815.txt   576138

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grtsq-20241113.xsd EX-101.SCH 2515
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtsq-20241113_lab.xml EX-101.LAB 17204
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtsq-20241113_pre.xml EX-101.PRE 10791
17 EXTRACTED XBRL INSTANCE DOCUMENT d844835d8k_htm.xml XML 3631
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 241467846
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)